ATLANTA & DALLAS, June 04, 2025--Chart Industries, Inc. (NYSE: GTLS) and Flowserve Corporation (NYSE: FLS) today announced that they have entered into a definitive agreement to combine in an all ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion.. Chart shareholders will receive 3.165 shares of ...

Research News New advances in science, medicine, health, and technology.Stem cell research, drug research, and new treatments for disease. Research News Subscribe to Health Newsletter ...

The all-stock merger between Chart and Flowserve was greeted with a material sell-off. On paper, the deal makes sense: synergies are valuable, the portfolio is diversified, and valuation now is ...

This includes research on coronavirus (SARS-CoV-2), tuberculosis (Mycobacterium tuberculosis), Shiga toxin-producing E. coli (STEC), and blastomycosis (Blastomyces dermatitidis). The facility supports ...

An artificial-intelligence model did something last month that no machine was ever supposed to do: It rewrote its own code to avoid being shut down. Nonprofit AI lab Palisade Research gave OpenAI ...

Chart shareholders will receive 3.165 shares of Flowserve common stock for each share of Chart common stock owned, resulting in Chart shareholders owning approximately 53.5% and Flowserve shareholders ...

India’s market regulator, Sebi, has proposed a five-point regulatory framework to govern the use of Artificial Intelligence ...

The pathogenesis of tendinopathy and the primary biological change in the tendon that precipitates pathology have generated several pathoaetiological models in the literature. The continuum model of ...